ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer

被引:1
|
作者
Li, Feng [1 ]
Ma, Jiahao [1 ]
Yan, Cheng [1 ]
Qi, Yonghua [1 ]
机构
[1] Xinxiang Univ, Diagnost Lab Anim Dis, Key Lab Nanocarbon Modified Film Technol Henan Pr, Sch Pharm, Xinxiang, Henan, Peoples R China
来源
关键词
Esophageal cancer; endoplasmic reticulum stress; mRNA; lncRNA; prognostic model; TUMOR-GROWTH; CELLS; MICROENVIRONMENT; IDENTIFICATION; EXPRESSION; INHIBITOR; CARCINOMA; APOPTOSIS; NETWORK; ROLES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal cancer (EC) is one of the most common malignant cancers in the world. Endoplasmic reticulum (ER) stress is an adaptive response to various stress conditions and has been implicated in the development of various types of cancer. Long noncoding RNAs (lncRNAs) refer to a group of noncoding RNAs (ncRNAs), which regulate gene expression by interacting with DNA, RNA and proteins. Accumulating evidence suggests that lncRNAs are critical regulators of gene expression in development, differentiation, and human diseases, such as cancers and heart diseases. However, the prognostic model of EC based on ER stress-related mRNA and lncRNA has not been reported. Methods: Firstly, we downloaded RNA expression profiles from The Cancer Genome Atlas (TCGA) and obtained ER stress-related genes from the Molecular Signature Database (MSigDB). Next, Weighted Correlation Network Analysis (WGCNA) co-expression analysis was used to identify survival-related ER stress-related modules. Prognostic models were developed using univariate and Least absolute shrinkage and selection operator (LASSO) regression analyses on the training set and validated on the test set. Afterwards, The Receiver Operating Characteristic (ROC) curve and nomogram were used to evaluate the performance of risk prediction models. Differentially expressed gene (DEG) and enrichment analysis were performed between different groups in order to identify the biological processes correlated with the risk score. Finally, the fraction of immune cell infiltration and the difference of tumor microenvironment were identified in high-risk and low-risk groups. Results: The WGCNA co-expression analysis identified 49 ER genes that are highly associated with EC prognosis. Using univariate Cox regression and LASSO regression analysis, we developed prognostic risk models based on nine signature genes (four mRNAs and five lncRNAs). Both in the training and in the test sets, the overall survival (OS) of EC patients in the high-risk group was significantly lower than that in the low-risk group. The Kaplan-Meier curve and the ROC curve demonstrate the prognostic model we built can precisely predict the survival with more than 70% accuracy. The correlation analysis between the risk score and the infiltration of immune cells showed that the model can indicate the state of the immune microenvironment in EC. Conclusion: In this study, we developed a novel prognostic model for esophageal cancer based on ER stress-related mRNA-lncRNA co-expression profiles that could predict the prognosis, immune cell infiltration, and immunotherapy response in patients with EC. Our results also may provide clinicians with a quantitative tool to predict the survival time of patients and help them individualize treatment strategies for the patients with EC.
引用
收藏
页码:8064 / +
页数:28
相关论文
共 50 条
  • [31] A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer
    Li, Linjing
    Li, Yuyi
    Lin, Junyi
    Pang, Wenjing
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [32] Identification of an Immune-Related Gene Signature Associated with Prognosis and Tumor Microenvironment in Esophageal Cancer
    Li, Chunzhen
    Zhou, Weizheng
    Zhu, Ji
    Shen, Qi
    Wang, Guangjie
    Chen, Ling
    Zhao, Tiejun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [33] Identification of oxidative stress-related subgroups and signature genes for the prediction of prognosis and immune microenvironment in thyroid cancer
    Zhenwei Qiu
    Jing Li
    Mei Tian
    Molecular Genetics and Genomics, 2025, 300 (1)
  • [34] An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer
    Wu, Zhenyu
    Wu, Zhenquan
    Zeng, Jie
    Liu, Yaxuan
    Wang, Yue
    Li, Huixin
    Xia, Taolin
    Liu, Weitao
    Lin, Zhe
    Xu, Wenfeng
    AGING-US, 2024, 16 (01): : 43 - 65
  • [35] The Novel-B-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Esophageal Carcinoma
    Li, Xinhong
    Sun, Tongyu
    Li, Hongyan
    Liu, Juan
    Huang, Na
    Liu, Surong
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1313 - 1323
  • [36] A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer
    Ma, Bin
    Cao, Lianqun
    Li, Yongmin
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2021, 18 (06) : 9743 - 9760
  • [37] Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
    Song, Dingli
    Zhou, Zhenyu
    Zhang, Dai
    Wu, Jie
    Hao, Qian
    Zhao, Lili
    Ren, Hong
    Zhang, Boxiang
    FRONTIERS IN GENETICS, 2022, 13
  • [38] Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma
    Chen, Hao
    Zhang, Kai
    Lu, Jian
    Wu, Guizhong
    Yang, Huilin
    Chen, Kangwu
    ONCOTARGET, 2017, 8 (68) : 112623 - 112635
  • [39] Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
    Zhang, Zhe
    Wang, Jian
    Han, Wei
    Zhao, Li
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [40] Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
    Zhe Zhang
    Jian Wang
    Wei Han
    Li Zhao
    BMC Gastroenterology, 23